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Abstract
 Takayasu Arteritis (TA) is a granulomatous inflammation of unknown aetiology affecting the aorta and its major 
branches with usual affliction among patients younger than 50 years and rarely among children. We present 
a 7-years old boy referred for evaluation of hypertension. He had a significant blood pressure difference between 
right arm, left arm and lower limbs. Computed tomography imaging of thorax and abdomen showed stenosis of 
left subclavian artery, left renal artery and juxtarenal aorta which was subsequently confirmed on aortogram. 
He underwent percutaneous endovascular therapy with aorto-renal bifurcation stenting with reduction of blood 
pressure and gradient. Renal angioplasty with stenting remains a challenging procedure in patients with tight ostial 
lesion, and juxtarenal aortic involvement in lieu of precise stent placement and avoiding side branch occlusion. 
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Introduction
Takayasu Arteritis is a chronic inflammatory disease 
that involves the aorta, its branches and the pulmonary 
arteries causing the varying degree of stenosis, dilatation 
or both. Despite being the third most frequent vasculitis 
in childhood, the occurrence of juvenile TA is scarce 
although youngest to be reported was 6-month old baby 
[1]. It is the commonest cause of renovascular hyper-
tension in Asian children as thoracoabdominal aorta is 
mainly involved in patients from Korea and India [2]. 
The usual symptom is due to hypertension, heart fail-
ure or a neurological event whereas claudication, bruit 
or a missing pulse in an asymptomatic child are quite 
uncommon thus the delay in its early diagnosis and 
consequently resulting in serious complications. TA in 
children is associated with higher morbidity and mor-
tality than adults [3]. Hypertension in Takayasu Arteritis 
results from renal artery stenosis or aortic narrowing 
and aortic fibrosis. Renal arterial stenosis may be bilat-
eral and usually coexists with aortic involvement [4]. 
It involves the ostia of the renal arteries sparing the 
intrarenal vasculature and small vessels. 
Case report
A 7-year old boy was admitted for evaluation of 
hypertension. There was no history of valvular heart 
disease. On examination, he looked small for his age 
with body weight 17 kg, conscious and afebrile. Blood 
pressure on right arm, left arm and both legs were 
136/86, 106/82 and 68/52 mm Hg respectively. On 
examination, there was absent pulse on tibial and fem-
oral arteries on both legs. Other examination findings 
were not remarkable. Therefore, blood pressure was 
labelled as stage II hypertension for this child [5]. The 
difference in blood pressure of ≥ 20 mm Hg between 
the upper and lower extremities suggested juvenile TA. 
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Laboratory investigations showed mild anaemia with 
haemoglobin 11.1 mg/dl, normal erythrocyte sedimen-
tation rate (ESR) and c-reactive protein (CRP). Chest 
skiagram and ophthalmologic evaluation were normal. 
Computed Tomography (CT) scan of the thorax and 
abdomen showed narrowing of the mid aorta, left 
subclavian artery and ostial involvement of left renal 
artery with atrophic right kidney (Fig. 1A). An aortog-
raphy revealed narrowing of descending thoracic and 
juxrarenal abdominal aorta, left subclavian artery and 
ostial involvement of left renal artery with 90% discrete 
stenosis (Fig. 1B, 2A). On gradual catheter pullback, 
transaortic pressure gradient was 80 mm Hg. Based on 
EULAR (European League Against Rheumatism)/PRES 
(Paediatric Rheumatology European Society) criteria, 
he was diagnosed as TA in remission stage [6]. Patient 
was planned for percutaneous transluminal angioplasty 
(PTA) for the treatment of stenosed descending thoracic 
and abdominal aorta and renal artery dilatation followed 
by bailout stenting. Access was gained through the 
right femoral artery (retrograde approach) using mi-
cropuncture set. 6F long sheath was advanced through 
a 0.035" terumo guidewire (Terumo, Japan). Sequential 
predilatation was performed, by 10 × 40 mm, and 12 × 
40 mm Mustang balloon (Boston Scientific, USA) up to 
10 atm pressure (Fig. 2B). Despite adequate dilatation, 
trans-aortic gradient was 40 mm Hg. Aorta was stented 
by deploying proximally EpicTM 19x60 mm and distally 
EpicTM 19 × 40 mm at 12 atm and 14 atm pressure 
with one strut overlap in between (Fig. 2C, D). The 
overlapping part was further dilated by the same distal 
stent balloon at 14 atms pressure. Aortography post 
angioplasty was performed with good results with no 
dissections. Residual trans-aortic pressure gradient was 
14 mm Hg. Left renal artery was cannulated with 6F re-
nal double curve (RDC) guiding catheter (Cordis Corp., 
USA) (Fig. 3A). 0.014" runthrough wire (Terumo, Japan) 
was parked distally (Fig. 3B). Lesion was predilated by 
2.5 × 10 mm, 3 × 10 mm Maverick semi-compliant 
balloon (Boston Scientific, USA) at 15 atms and 3.5 × 
12 noncompliant balloon at 20 atms pressure to open 
up the lesion as it appeared fibrotic (Fig. 3 C, D). It was 
stented with 5 × 19 mm Hippocampus bare metal stent 
(Medtronic, USA) with 1–2 mm of stent overhanging into 
the aorta to ensure ostial coverage and was deployed at 
Figure 1. CT angio of abdomen showing critical stenosis of 
left renal artery and atrophic right kidney (white arrow, A); 
Thoracic DSA showing stenosis of left subclavian artery (white 
arrow, B) 
Figure 2. A — abdomen DSA showing narrowing of descen-
ding thoracic and juxrarenal abdominal aorta, and left renal 
artery; B — predilatation of aorta by semicompliant balloon; 
C — endovascular deployment of proximal stent; D — distal 
stent overlapping with proximal stent in juxta renal aorta
Figure 3. A — left renal artery was cannulated with renal do-
uble curve (RDC) guiding catheter; B–D — predilatation of le-
sion with semi compliant balloon after wiring with runthrough 
coronary guide wire
A B
C D
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9 atms pressure (Fig. 4A). The stent-balloon assembly 
was further pulled into the aorta and inflated at 14 atms 
to flare the ostia (Fig. 4B, 5A). The same balloon was 
further pushed up along the guiding catheter and inflated 
at 16 atms to properly flare and funnell the ostia (Fig. 
5B). It was done to ensure that guiding catheter could be 
coaxially placed in future in case any restenosis occurs. 
The final angiogram revealed optimally deployed stents 
(Fig. 6, 7A–C). The patient was started on aspirin 75 
mg, amlodipine 10 mg and hydrochlorothiazide 12.5 mg 
once daily and subsequently discharged. After 6 months’ 
follow-up, blood pressure was stable at 100/60 mm Hg 
and CT angiogram revealed well expanded and patent 
stents (Fig. 7D). 
Discussion
The onset of illness in TA may be earlier, including in 
childhood but rarely in infancy [3]. Hypertension in pa-
tients with TA is either detected incidentally or present 
with complications such as hypertensive encephalopa-
thy or heart failure. Patients with juvenile TA generally 
present below the age of 8 years with non-specific 
systemic symptoms such as fever and weight loss in 
contrast to adult patients, who usually present with 
hypertension, decreased peripheral artery pulsations or 
claudication of the extremities. Vascular involvement is 
similar to adult population though less frequent.
Assessing disease activity in patients with Takayasu 
arteritis is frequently challenging since clinical, bi-
ologic, and radiologic information do not always 
correlate. In our case, TA was diagnosed and active 
stage was ruled out on the basis of EULAR/PRINTO/
PRES/Prospective study criteria established by Kerr 
et al. [7, 8] which includes ESR > 20 mm per hour 
or CRP above normal as acute phase reactant. It is 
important to identify active disease since this requires 
immunosuppressive treatment, but its role in the late 
Figure 7. A–C — abdomen DSA showing optimally deployed 
stents; D — CT angiogram showing well expanded and patent 
stents on 6 months follow up
Figure 4. A — stenting of left renal artery with 7 × 19 mm 
Hippocampus bare metal stent with 1–2 mm of stent overhan-
ging in the aorta; B — flaring of the ostia
Figure 5. Funelling of ostia by further pulling and pushing up 
the balloon 
Figure 6. Abdomen DSA showing optimally deployed renal 
stent with proper ostial coverage
A B
C D
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stage of the disease is unclear when a risk-benefit 
balance must be made.
Clinicians currently combine clinical features with 
acute phase reactants such as the erythrocyte sedimen-
tation rate and/or C reactive protein; imaging techniques 
such as positron emission tomography (PET-CT) [9], 
contrast-enhanced magnetic resonance imaging (MR) 
[10], and CT angiography [11], and formal digital sub-
traction arteriography (DSA), perceived by most to be 
the gold standard for defining lumenography to monitor 
for disease activity and for stenotic sequelae. 
The uptake of 18F-fluorodeoxyglucose on PET imaging 
is reported to be highly sensitive and accurate method 
for assessing disease activity in patients with TA with the 
sensitivity and specificity of 73–100% and 83–92%, re-
spectively [12]. In our case, the absence of constitutional 
symptoms with normal ESR and CRP leads us to conclude 
that patient was not in active phase of the disease.
Digital subtraction catheter arteriography is of par-
ticular importance in the assessment of patients po-
tentially requiring revascularization procedures such as 
angioplasty and/or stenting, or more invasive surgical 
interventions such as aortic bypass grafting which is-
commonly required to provide relief from symptomatic 
ischaemia [13–15]. 
Pentraxin-3 (PTX3), a member of the superfamily 
of acute- phase proteins such as c-reactive protein 
(CRP) and serum amyloid P, has been shown to be more 
accurate than the ESR and CRP level for differentiating 
active from inactive disease in patients with previously 
diagnosed TA. In a cross-sectional study, PTX3 >1 ng/
mL were more accurate than normal thresholds of CRP 
and ESR for defining disease activity [16]. Certainly, it may 
play a future role as a possible disease marker but needs 
to be assessed in a broader spectrum of patients whose 
disease activity is unknown or equivocal before recom-
mending it clinically as pointed out by Danga et al. [16]. 
Initially, steroids are used as an immunosuppresant 
and cytotoxic agents are reserved for patients whose 
disease is either steroid resistant or relapsing. Methotrex-
ate, azathioprine, and cyclophosphamide are among the 
drugs used in TA, with cyclophosphamide being reserved 
for patients with the most severe and refractory disease 
states. As our patient was in the state of remission, no 
immunosuppression was prescribed.
 Percutaneous transluminal angioplasty (PTA) in 
children has high-success rate close to 90% [4, 17]. Im-
portant considerations in determining the overall efficacy 
of these procedures are the rates of restenosis after 
angioplasty. In the study among 13 patients by Colyer et 
al. [18], an overall restenosis rate of 18% with a rate of 
40% with balloon angioplasty alone wasnoted. Similarly, 
in a study by Zhu et al among 22 children which were fol-
lowed up for 13 years, rate of restenosis was 41% [19]. 
In another study among 33 children as reported by 
Shroff et al. [20] restenosis was reported among 40% 
who had undergone stenting over 20 years of follow up. 
The varying rate may be due to small patient sample or 
a significant selection bias, as only the most severe pa-
tients were referred for catheterization and intervention. 
The smaller diameter of the vessel and the possible 
effect of growth factors on the child’s vasculature may 
account for the higher restenosis rate than reported in 
adult series. Therefore, stents have not been accepted 
for paediatric population despite significant restenosis 
rates following balloon angioplasty alone, due to inherent 
problems of prosthetic material in this population. They 
have been successfully used to treat occlusive dissecting 
flaps or aortic obstruction [17]. For ostial lesions, which 
are encountered most frequently, stenting is preferred to 
balloon dilatation as these lesions are elastic and respond 
poorly to balloon dilatation alone and associated with 
higher procedural success rate (98% vs. 77%) and the 
lower rate of the restenosis (17% vs. 26%) [21]. 
In our case, as the child had a single normally func-
tioning kidney (other atrophic and non-functioning), we 
were reluctant to end the procedure with a residual 90% 
stenosis following balloon dilatation. For salvaging kidney 
function, to prevent kidney failure and to hypertension, 
bailout stenting was performed. Also, in future in the 
event of restenosis or relative stenosis when the renal 
artery increases in size, the 5 mm stent can be further 
expanded up to 7 mm by balloon dilatation. Restenosis 
may also be dealt with cutting balloons or drug-eluting 
balloons should it occur in future. Like coronary arteries, 
it is possible that cutting balloon angioplasty could have 
given a better angiographic result but currently, there 
is lack of evidence with use of cutting balloons in young 
children. Also, the upward orientation of the renal artery 
and the resultant sharp angle vis-a-vis the guide catheter, 
we decided that stenting was the safest option to salvage 
the only functioning kidney. Furthermore, renal artery 
rupture has been reported to occur even in adults fol-
lowing cutting balloon angioplasty [20]. Another option 
could have been the use of bio-resorbable scaffold (BRS), 
but the limitation with current generation stents was its 
diameter as largest available diameter is 3.5 mm. Also, it 
is associated with increased risk of stent thrombosis [22].
Because of the diffuse, inflammatory and possibly 
progressive nature of the disease, surgical treatment is 
not preferred for Takayasu arteritis except for undilatable 
symptomatic stenotic lesions and for large aneurysms [3]. 
In view of underlying disease, drug-eluting stents 
(DES) are the best option [23]. At present, coronary 
DES are used in the renal arteries as dedicated DES for 
renal artery are not available. Despite recent randomised 
trials showing no benefit of renal artery stenting against 
medical management, the benefit of renal angioplasty 
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still remains in selected cases of renal artery stenosis 
[24, 25]. Superiorly angulated renal arteries are best 
approached from below, allowing natural orientation 
of balloon and stent with the vessel, as was performed 
in the present case. Also, we pushed the balloon little 
up during post-dilatation of renal stent to properly flare 
the upper margin of stent so that it would help in future 
rewiring had any restenosis will be encountered (Fig. 5B). 
Our case report highlights the procedural challenge and 
excellent clinical outcome achieved in a patient with 
renal artery stenosis with juxtaposed aortic involvement.
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